Revvity, Inc.
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions s…
Medical - Diagnostics & Research
US, Waltham [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Revvity, Inc.'s gradings, price targets and earnings estimates. None
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2015 | - | 2.574 | - | 2,272 | - | 321 | - | 678 | - | 457 | - | 598 |
| 2016 | - | 2.756 | - | 2,264 | - | 344 | - | 676 | - | 455 | - | 596 |
| 2017 | - | 2.893 | - | 2,233 | - | 361 | - | 667 | - | 449 | - | 588 |
| 2018 | - | 3.604 | - | 2,770 | - | 449 | - | 827 | - | 557 | - | 729 |
| 2019 | - | 4.074 | - | 2,880 | - | 508 | - | 860 | - | 580 | - | 758 |
| 2020 | - | 7.360 | - | 3,653 | - | 918 | - | 1,091 | - | 735 | - | 961 |
| 2021 | - | 11.038 | - | 4,976 | - | 1,377 | - | 1,486 | - | 1,001 | - | 1,310 |
| 2022 | - | 7.784 | - | 4,589 | - | 971 | - | 1,370 | - | 924 | - | 1,208 |
| 2023 | - | 4.560 | - | 2,731 | - | 569 | - | 816 | - | 550 | - | 719 |
| 2024 | - | 4.846 | - | 2,758 | - | 604 | - | 824 | - | 555 | - | 726 |
| 2025 | - | 5.175 | - | 2,909 | - | 642 | - | 869 | - | 585 | - | 765 |
| 2026 | - | 5.805 | - | 3,107 | - | 709 | - | 928 | - | 625 | - | 818 |
| 2027 | - | 6.410 | - | 3,315 | - | 1.F12X/td> | - | 1.F121/td> | - | 1.F121 | - | 1.F121 |
| 2028 | - | 7.125 | - | 3,478 | - | 0.F13X/td> | - | 0.F131/td> | - | 0.F131 | - | 0.F131 |